Clinical Characteristic | Category | HR (Univariate) 95% CI |
---|---|---|
Sex | Male | 1.06 (0.48–2.36) |
Female (Ref.) | ||
Age (≥ vs. < 51 years) | < 51 years | 1.57 (0.72–3.42) |
≥51 years (Ref.) | ||
Region of recurrence | Pelvic | 0.81 (0.38–1.70) |
Retroperitoneal (Ref.) | ||
Local failure | No | 2.79 (1.31–5.95) |
Yes (Ref.) | ||
Resection grade | R0 | 1.87 (0.82–4.27) |
R1 (Ref.) | ||
Association with first-line EBRT | Yes | 0.53 (0.24–1.16) |
No (Ref.) | ||
Association with adjuvant EBRT | Yes | 1.16 (0.55–2.45) |
No (Ref.) | ||
Association with neoadjuvant chemotherapy | Yes | 0.42 (0.12–1.43) |
No (Ref.) | ||
Association with adjuvant chemotherapy | Yes | 1.65 (0.57–4.78) |
No (Ref.) | ||
Distant failure | Yes | 0.43 (0.18–0.99) |
No (Ref.) | ||
Histology | Sarcoma (Ref.) | 2.75 (1.31–5.75) |
Epithelial | ||
Colorectal Tumor | Yes (Ref.) | 0.47 (0.19–1.16) |
No | ||
Retroperitoneal Sarcoma | Yes (Ref.) | 2.81 (1.33–5.94) |
No | ||
Gynecological Tumor | Yes (Ref.) | 0.73 (0.34–1.58) |
No |